This Article Full Text (PDF) References Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in ISI Web of Science Similar articles in PubMed Alert me to new issues of the journal Add to Saved Citations Download to citation manager Request Permissions Request Reprints Add to My Marked Citations Citing Articles Citing Articles via ISI Web of Science (2) Citing Articles via Google Scholar Citing Articles via Scopus Google Scholar Articles by Hardej, D. Articles by Billack, B. Search for Related Content PubMed PubMed Citation Articles by Hardej, D. Articles by Billack, B. Pubmed/NCBI databases Compound via MeSH Substance via MeSH Medline Plus Health Information Biodefense and Bioterrorism Chemical Emergencies Hazardous Substances DB MECHLORETHAMINE Social Bookmarking                   What's this?

Ebselen protects brain, skin, lung and blood cells from mechlorethamine toxicity

Department of Pharmaceutical Sciences, College of Pharmacy and Allied Health Professions, St John's University, Queens, NY, USA

Blase Billack

Department of Pharmaceutical Sciences, College of Pharmacy and Allied Health Professions, St John's University, Queens, NY, USA, billackb{at}stjohns.edu

Nitrogen mustards are vesicants capable of burning the skin, eyes and respiratory tract of exposed individuals. While generally less toxic than sulfur mustards, these compounds have the potential for use as chemical warfare agents. Presently, no antidote exists for treatment against nitrogen mustard toxicity. The purpose of this study was to investigate the in vitro toxicity of the nitrogen mustard mechlorethamine (HN2) in four cell models: CEM-SS human T cells, A431 human skin epithelial cells, rat hippocampal astrocytes and rat pleural mesothelial cells. Furthermore, the efficacy of the synthetic seleno-organic compound ebselen (Eb) (2-phenyl-1,2- benzisoselenazol-3(2H)-one) as a cytoprotective agent against such toxicity was evaluated. Significant increases in cell viability, as assessed using an MTT assay for viability, was demonstrated when 30µM Eb was used as a cotreatment with HN2 in all cell models tested at the following doses of HN2: A431 skin cells,10—40µM; rat astrocytes, 20 and 40µM; rat mesothelia, 10—40 µM; and human T cells 4—16 µM. Decreases in cell viability and toxicity to HN2 were confirmed using light and scanning electron microscopy. Membrane damage, observed with HN2 exposure, such as blebbing and loss of cell projections, was ameliorated with Eb cotreatment. Our results demonstrate a generalized protective effect observed with Eb cotreatment that suggests that this agent may have potential as an antidote for HN2 exposure and toxicity.

Key Words: ebselen • in vitro toxicology • nitrogen mustard

Toxicology and Industrial Health, Vol. 23, No. 4, 209-221 (2007)
DOI: 10.1177/0748233707083541


CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?